Trials / Not Yet Recruiting
Not Yet RecruitingNCT07353736
Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
Hemodynamic Mechanisms, Clinical Profiles, and Prognostic Factors in Patients With Cerebral Arteriovenous Malformations and Intracranial Aneurysms: An Observational Cohort Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 630 (estimated)
- Sponsor
- Duan Chuanzhi · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.
Detailed description
This study aims to evaluate the clinical safety and efficacy of different treatment strategies in patients with cerebral arteriovenous malformations (AVMs) combined with intracranial aneurysms (IAs) through a multicenter, large-sample, prospective observational cohort study. It will comprehensively analyze the epidemiological characteristics, clinical manifestations, associated risk factors, natural disease progression, and bleeding risks, as well as explore the hemodynamic mechanisms and genetic background differences. Clinical data, imaging findings, and blood samples will be collected from patients to investigate the impact of hemodynamics on aneurysm formation, rupture risk, and treatment outcomes. Additionally, the study will explore the genetic differences of AVM and IA patients and their correlation with clinical presentation and prognosis, ultimately providing a scientific basis for individualized treatment strategies.
Conditions
- Cerebral Arteriovenous Malformation
- Intracranial Arterial Diseases
- Intra Cerebral Hemorrhage
- Intracranial Aneurysm
- Brain Diseases
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2030-11-30
- Completion
- 2030-12-30
- First posted
- 2026-01-20
- Last updated
- 2026-01-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07353736. Inclusion in this directory is not an endorsement.